Age at menopause and cognitive function and decline among middle-aged and older women in the China Health and Retirement Longitudinal Study, 2011–2018

IF 11.1 1区 医学 Q1 CLINICAL NEUROLOGY Alzheimer's & Dementia Pub Date : 2025-02-12 DOI:10.1002/alz.14580
Muqi Guo, Yingyan Wu, Alden L. Gross, Carrie Karvonen-Gutierrez, Lindsay C. Kobayashi
{"title":"Age at menopause and cognitive function and decline among middle-aged and older women in the China Health and Retirement Longitudinal Study, 2011–2018","authors":"Muqi Guo,&nbsp;Yingyan Wu,&nbsp;Alden L. Gross,&nbsp;Carrie Karvonen-Gutierrez,&nbsp;Lindsay C. Kobayashi","doi":"10.1002/alz.14580","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> INTRODUCTION</h3>\n \n <p>Chinese women experience higher dementia rates than men, yet sex-specific risk factors are understudied. We examined how menopause age affects cognitive function and decline in aging Chinese women.</p>\n </section>\n \n <section>\n \n <h3> METHODS</h3>\n \n <p>Data were from 7419 postmenopausal women 45–101 years of age at baseline in the China Health and Retirement Longitudinal Study (CHARLS; 2011–2018). Menopause age was categorized using clinical cutoffs (&lt;40, 40–44, 45–49, 50–55, &gt;55 years). Cognitive function was assessed with neuropsychological tests up to four times over 7 years, and associations were analyzed using multivariable-adjusted linear mixed-effects regression.</p>\n </section>\n \n <section>\n \n <h3> RESULTS</h3>\n \n <p>Compared to menopause at 50–55 years (3661/7419; 49.3%), premature (&lt;40; 235/7419; 3.2%), early (40–44; 623/7419; 8.4%), and late menopause (&gt;55; 366/7419; 4.9%) were associated with lower baseline cognitive scores. Although the rate of cognitive decline did not differ significantly across menopause age groups, late menopause showed a trend toward faster decline.</p>\n </section>\n \n <section>\n \n <h3> DISCUSSION</h3>\n \n <p>Cognitive health interventions should consider extreme menopausal age as a risk factor.</p>\n </section>\n \n <section>\n \n <h3> Highlights</h3>\n \n <div>\n <ul>\n \n <li>Extreme menopausal ages—premature (&lt;40), early (40–44), and late (&gt;55)—are linked to lower baseline cognition versus menopause ages 50–55, persisting over 7 years.\n</li>\n \n <li>Cognitive disadvantage for late menopause (&gt;55) versus 50–55 tends to increase over time.</li>\n \n <li>Health interventions should consider extreme menopause ages in women's cognitive health.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":11.1000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14580","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14580","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION

Chinese women experience higher dementia rates than men, yet sex-specific risk factors are understudied. We examined how menopause age affects cognitive function and decline in aging Chinese women.

METHODS

Data were from 7419 postmenopausal women 45–101 years of age at baseline in the China Health and Retirement Longitudinal Study (CHARLS; 2011–2018). Menopause age was categorized using clinical cutoffs (<40, 40–44, 45–49, 50–55, >55 years). Cognitive function was assessed with neuropsychological tests up to four times over 7 years, and associations were analyzed using multivariable-adjusted linear mixed-effects regression.

RESULTS

Compared to menopause at 50–55 years (3661/7419; 49.3%), premature (<40; 235/7419; 3.2%), early (40–44; 623/7419; 8.4%), and late menopause (>55; 366/7419; 4.9%) were associated with lower baseline cognitive scores. Although the rate of cognitive decline did not differ significantly across menopause age groups, late menopause showed a trend toward faster decline.

DISCUSSION

Cognitive health interventions should consider extreme menopausal age as a risk factor.

Highlights

  • Extreme menopausal ages—premature (<40), early (40–44), and late (>55)—are linked to lower baseline cognition versus menopause ages 50–55, persisting over 7 years.
  • Cognitive disadvantage for late menopause (>55) versus 50–55 tends to increase over time.
  • Health interventions should consider extreme menopause ages in women's cognitive health.

Abstract Image

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2011-2018年中国健康与退休纵向研究中老年妇女绝经年龄与认知功能下降
中国女性患痴呆症的比例高于男性,但性别相关的风险因素尚未得到充分研究。我们研究了绝经年龄如何影响中国老年妇女的认知功能和衰退。方法:数据来自中国健康与退休纵向研究(CHARLS;2011 - 2018)。绝经年龄采用临床截止年龄(40岁、40 - 44岁、45-49岁、50-55岁、55岁)进行分类。认知功能在7年内通过神经心理测试评估多达4次,并使用多变量调整线性混合效应回归分析相关性。结果与50-55岁绝经妇女相比(3661/7419;49.3%),过早(<40;235/7419;3.2%),早期(40-44岁;623/7419;8.4%)和绝经后期(>55;366/7419;4.9%)与较低的基线认知评分相关。虽然认知能力下降的速度在绝经年龄组之间没有显著差异,但绝经后期表现出更快的下降趋势。认知健康干预应考虑极端绝经年龄作为一个危险因素。极端绝经年龄——过早(40岁)、过早(40 - 44岁)和晚(55岁)——与50-55岁的绝经年龄相比,认知基线较低,持续7年以上。晚期绝经(>55)与50-55相比,认知缺陷随着时间的推移而增加。健康干预应考虑到妇女认知健康的极端绝经年龄。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Alzheimer's & Dementia
Alzheimer's & Dementia 医学-临床神经学
CiteScore
14.50
自引率
5.00%
发文量
299
审稿时长
3 months
期刊介绍: Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.
期刊最新文献
The Alzheimer's Disease Diagnosis and Plasma Phospho‐Tau217 (ADAPT) study stage 1: Validating clinical cut‐points against CSF and amyloid PET Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease Plasma p-tau217 predicts PET-based pathological staging for precision Alzheimer disease assessment Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection A Randomized Trial Using PARO with Minimal Caregiver Involvement on Older Adults with Dementia in Group Homes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1